Study Notes on Causal Inference and Experimental Design

Causal Inference

Pre & Post-Test Experimental Design

  • Focuses on understanding the true effects of treatments in research settings.

Field Experiments Over Time

  • Field experiments may face various external factors impacting outcomes.

  • Example: Testing two types of promotions that require a time span of 1–4 weeks:
      - During this time, external factors can shift consumer purchase decisions.

  • Importance of classifying these extraneous factors in order to evaluate effectiveness accurately.

Threats to Experiments

Extraneous Variables

  • Definition: Factors that can confound the treatment effect over time, potentially skewing results.

Types of Extraneous Variables
  1. History (H)
       - Definition: Specific events outside of the experimental control occurring during the experiment.
       - Examples: Changes in economic conditions, natural disasters occurring concurrent with the study timeline.

  2. Maturation (MA)
       - Definition: Changes in test units resulting from growth or temporal effects over time.
       - Examples: Aging, mood changes, or other psychological shifts affecting participants during the study.

Comparison: History vs. Maturation
  • History
      - Involves changes in the external environment that may affect all groups.

  • Maturation
      - Involves changes within the test units themselves.

Testing Effects

  • Related to the act of measuring participants before and after treatment.
      - Participants exposed to products prior to the test may create a consistent opinion affecting post-experiment responses.

  • Main Testing Effect (MT): Prior observations influence later observations in both treatment and control groups.

  • Interaction Testing Effect (IT): This effect only occurs in the treatment group as a consequence of the treatment itself.

More Extraneous Variables

  1. Instrumentation (I)
       - Definition: Changes in the measurement tools or observers during the experiment can skew results.

  2. Mortality (MO)
       - Definition: Loss of participants while the experiment is ongoing.
       - Participants dropping out can introduce bias, particularly if the dropout is related to the treatment.

  3. Selection Bias (SB)
       - Definition: Concerns arise when non-random assignment occurs for test units across treatment and control conditions.
       - Groups must not differ significantly in traits or motivations; otherwise, results may be invalid.
       - Importance of randomization in eliminating selection bias.

Extraneous Variables Summary

  • H: History - External events during the experiment.

  • MA: Maturation - Changes in test units over time.

  • MT: Main Testing - A prior observation affecting a later one (both groups).

  • IT: Interaction Testing - Testing effect only present in the treatment group.

  • I: Instrumentation - Changes in measurement tools during the study.

  • MO: Mortality - Loss of test units during the experiment.

  • SB: Selection Bias - Non-random assignment to groups.

True Experimental Design

Pre & Posttest Control Group Design

  • Pretest-Posttest Design: Structure for measuring treatment effects in controlled environments.
       - Notation:
       - Treatment Group (TG): RextO1extXextO2R ext{ } O_1 ext{ } X ext{ } O_2
       - Control Group (CG): RextO3extO4R ext{ } O_3 ext{ } O_4
       - Key Elements:
         - R = Randomization
         - O = Observation
         - X = Treatment
       - Random assignment of test units to either treatment or control conditions helps eliminate selection bias.
       - Measuring Treatment Effect:
         (O2O1)(O4O3)(O_2 - O_1) - (O_4 - O_3).

Difference-in-Differences (DiD)

  • Treatment effect measured as:
    (O2O1)(O4O3)(O_2 - O_1) - (O_4 - O_3)

  • Breakdown of Results:
      - O2O1=TE+H+MA+MT+IT+I+MOO_2 - O_1 = TE + H + MA + MT + IT + I + MO
      - O4O3=H+MA+MT+I+MOO_4 - O_3 = H + MA + MT + I + MO

  • Note: Interaction Testing effect (IT) not fully eliminated, leading to residual contamination in the estimate.

The Remaining Problem: Interaction Testing (IT)

  • Variables Potentially Eliminated by DiD:
      - History (H): Yes
      - Maturation (MA): Yes
      - Main Testing (MT): Yes
      - Instrumentation (I): Yes
      - Mortality (MO): Yes
      - Selection Bias (SB): Yes (via randomization)
      - Interaction Testing (IT): No (still present).

Solution: The Placebo

  • Placebo Use: Assign control group a placebo treatment.
      - Ensures both groups are exposed to similar testing conditions, allowing the interaction testing effect (IT) to cancel out during analysis.
      - Allows for accurate calculation of treatment effect:
    (O2O1)(O4O3)=TE(O_2 - O_1) - (O_4 - O_3) = TE.

In-Class Exercise

  • Hands-on Analysis:
       - Experiment with a pre-post dataset (experiment_(pre post).xlsx).
       - Task:
         - Apply the Pretest-Posttest Control Group Design.
         - Assess the randomization balance using pre-treatment characteristics.
         - Estimate treatment effect utilizing the Difference-in-Differences methodology.

Comparison of Experimental Designs

Post-Test Only vs. Pretest-Posttest Design

  • Post-Test Only Design:
      - Involves analyzing one period of data (post-treatment results).
        1. Evaluate significant differences in characteristics between control group (CG) and treatment group (TG).
        2. If not significant, assess average outcome differences.
        3. Significant results suggest treatment effectiveness; if not significant, treatment is ineffective.

  • Pretest-Posttest Design:
      - Incorporates two time periods (pre- and post-treatment).
        1. Evaluate differences in pre-treatment characteristics between CG and TG.
        2. If not significant, calculate the difference-in-differences (post–pre).
        3. Significant outcomes validate treatment effectiveness. If not significant, treatment is ineffective.

Key Assumption

SUTVA

  • SUTVA: Stable Unit Treatment Value Assumption

  • Fundamental requirement that outcomes of participants should be independent of others.

  • Potential Violation Scenario:
      - Example: Vaccination randomized controlled trial (RCT).
        - If vaccinated participants reduce disease transmission, control participants benefit from spillover effects, violating SUTVA’s independence assumption.